GrowLife, CEN Biotech Partner on Huge Growing Facility

Two marijuana companies are partnering to build a large cultivation facility in Canada, just a stone’s throw away from downtown Detroit.

CEN Biotech and Organic Growth International, which is partially owned by GrowLife Inc., are partnering on the $16 million facility, which is being built in Lakeshore, Ontario. When fully operational, the facility could produce up to 1.3 million pounds of marijuana annually, the companies said.

The companies hope to eventually export marijuana grown in the facility into the United States.

CEN Biotech is the Canadian subsidiary of the Michigan-based Creative Edge Nutrition, which recently received tentative approval from Canada to export marijuana.

CEN Biotech has completed the lengthy process of winning government approval for the site of the new building. The companies have not established a timeline for when the facility could begin growing marijuana.

The partnership between the two companies has also created a new corporate ownership structure. Grow Life now owns a 25% equity position in CEN Biotech, which entitles it to licensing fees and a percentage of all gross payments received by CEN Biotech. GrowLife will also supply all growing equipment and infrastructure to the new facility.

“The scale of the planned operations is truly unprecedented for legal cannabis worldwide,” said GrowLife CEO Sterling Scott in a press release.

3 comments on “GrowLife, CEN Biotech Partner on Huge Growing Facility
  1. Bob on

    To bad farms outside will put these guys out of buisness! Good luck beating farm land prices. You will have to much over head to compete.

    Reply
  2. Chris on

    Bob, I don’t think you understand how a country run, medicinal marijuana facility needs to operate. It can’t just be a “farm”. There are consistant standards that need to be met as well as many different strains of marijuana that need to be grown for specific ailments. All needing controlled temperatures…and different temperatures throughout photosynthesis. The product needs to test between a small allowed THC range and can not vary much at all. And not to mention, without licensing from the country, penalties from being caught growing will be much tougher than they are currently. Governments are going to have a stranglehold on this product because they want the big FAT taxes coming from production and sales of marijuana.
    There isn’t a “farm” anywhere that’s going to get the licensed ability to sell medicinally through dispensaries via certified physician prescription.

    Reply
  3. Christina on

    They need to stick to selling it in Canada, in the US we should keep the money flow local and in our own economy. Patients that grow for themselves currently do not want to lose that option, and if they DID want someone else to grow it and profit from it I DOUBT it would be someone other than their own community.

    Reply

Leave a Reply

Your email address will not be published. Required fields are marked *